summary
Introduced
10/01/2015
10/01/2015
In Committee
04/28/2016
04/28/2016
Crossed Over
05/12/2016
05/12/2016
Passed
Dead
01/03/2017
01/03/2017
Introduced Session
114th Congress
Bill Summary
Co-Prescribing to Reduce Overdoses Act of 2016 (Sec. 2) This bill permits the Department of Health and Human Services (HHS) to establish a grant program to support prescribing opioid overdose reversal drugs, such as naloxone, for patients at an elevated risk of overdose, including patients prescribed an opioid. (Opioids are drugs with effects similar to opium, such as heroin and certain pain medications.) Grant recipients may use the funds to purchase opioid overdose reversal drugs, establish a program for prescribing such drugs, train health care providers and pharmacists, track patients and outcomes, offset patient cost sharing, conduct community outreach, and connect patients to treatment. (Sec. 3) HHS may provide information to prescribers in federally qualified health centers and Indian Health Service facilities on best practices for prescribing opioid overdose reversal drugs for patients at an elevated risk of overdose. (Sec. 4) This bill amends the Public Health Service Act to reduce, as an offset, the authorization of appropriations for Centers for Disease Control and Prevention facilities for FY2018.
AI Summary
This bill, the Co-Prescribing to Reduce Overdoses Act of 2016, establishes a grant program managed by the Department of Health and Human Services (HHS) to support the prescribing of opioid overdose reversal drugs, such as naloxone, to individuals at high risk of overdose, including those prescribed opioids. Opioids are a class of drugs, like heroin and certain pain relievers, that have effects similar to opium. The grants can be used for purchasing these reversal drugs, setting up prescribing programs, training healthcare providers and pharmacists, tracking patient outcomes, reducing patient out-of-pocket costs for these medications, conducting community awareness campaigns, and connecting patients with treatment options. Additionally, HHS will provide information on best practices for prescribing these overdose reversal drugs to prescribers in federally qualified health centers and Indian Health Service facilities. As an offset, the bill reduces the authorized appropriations for Centers for Disease Control and Prevention facilities for fiscal year 2018.
Committee Categories
Business and Industry, Health and Social Services
Sponsors (6)
John Sarbanes (D)*,
Gus Bilirakis (R),
Larry Bucshon (R),
Randy Hultgren (R),
Martha McSally (R),
Bill Shuster (R),
Last Action
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (on 05/12/2016)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...